Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 678.00
-10.00 (-1.45%)
At close: Feb 11, 2026
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 43.78 billion as of February 20, 2026. Its market cap has increased by 846.78% in one year.
Market Cap
43.78B
Enterprise Value
43.58B
Revenue
29.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
678.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 43.78B, an increase of 687.99%. That is a compound annual growth rate of 191.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 43.78B | 118.23% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 30.15B |
| Oneness Biotech | 27.84B |
| Polaris Group | 23.04B |
| Sunmax Biotechnology | 21.21B |
| EirGenix | 18.52B |
| TaiMed Biologics | 14.67B |
| AP Biosciences | 14.38B |